Patents

Patents

27. Novel pharmaceutical composition for treating neurodegenerative diseases. Pending

26. Composition for differentiation of stem cells into chondrocytes comprising FGF2-RGD fusion protein. Pending

25. Bioactive recombinant insulin-like growth factor-1 fusion protein and use thereof. Pat. No: 10-2599111

24. A novel single domain antibody targeting CEA and use thereof. Pending

23. Recombinant immunotoxin targeting HER2 and pharmaceutical composition for preventing or treating cancer comprising the same. Pending

22. Recombinant immunotoxin targeting carcinoembryonic antigen and pharmaceutical composition for preventing or treating cancer comprising the same. Pending 

21. A novel GSK3 inhibiting compound, a process for producing the same, and a usage comprising the same. Pat. No: 10-2611617

20.  Method for soluble overexpression and purification of recombinant human serum albumin. Pat. No: 10-2060881

19.  Method for soluble overexpression and purification of active WKYMVM peptide fused with albumin binding nanobody. Pat. No: 10-22206762

18. Prokaryotic soluble expression and purification of bioactive human fibroblast growth factor 21. Pat. No: 10-2006101

17. Soluble overexpression of human granulocyte colony stimulating factor in E. coli and its simple purification as a bioactive form. Pat. No: US15/025,283

16. Soluble overexpression and purification method of bioactive recombinant human interferon alpha 2b. Pat. No: 10-1828672 

15. Soluble overexpression and purification method of active recombinant human vascular endothelial growth factor. Pat. No: 10-1723306

14. Recombinant microorganism producing Crotamine protein and method for Production of Crotamine protein Using Thereof. Pat. No: 10-1717238

13. Soluble overexpression of human granulocyte colony stimulating factor in E. coli and its simple purification as a bioactive form. Pat. No: PCT/KR2014/008876

12. Soluble expression of human growth hormone with maltose binding protein in Escherichia coli and its simple purification. Pat. No: 10-1517297

11. Soluble overexpression of human granulocyte colony stimulating factor in E. coli and its simple purification as a bioactive form. Pat. No: 10-1557196

10. Prokaryotic soluble expression and purification of bioactive chemokine (C-C motif) ligand 2. Pat. No: 10-1508056

9. Prokaryotic Soluble Expression and Purification of an Active Dickkopf 2 (Dkk2). Pat. No: 10-1508052

8. Expression and purification of biologically active human leukemia inhibitory factor with hPDIb'a' tag in Escherichia coli. Pat. No: 10-1434739

7. Soluble overexpression of human EC-SOD in E. coli and purification in active form. Pat. No: 10-1429342

6. Expression and purification method of biological active human FGF2 with human PDIb´a´ domain in Escherichia coli. Pat. No: 10-1434734

5. Soluble overexpression and purification method of biological active recombinant human BMP7 in Escherichia coli. Pat. No: 10-1411456

4. Expression Vector for Human Erythropoietin and Process for Production of Erythropoietin Using Thereof. Pat. No: 10-1364864

3. Okadaic acid-induced neurodegenerative cell model for screening GSK-3β inhibitor in Alzheimer's disease. Pat. No: 10-1093798

2. Shape-based Virtual Drug Screening Method using the Negative Image of a Ligand-binding Site. Pat. No: 10-1128606

1. Adeno-Associated Virus Serotype 5 Vector for Targeted Gene Delivery. Pat. No: 10-0912270